Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 60.

Dawes, John M; Weir, Greg A; Middleton, Steven J; et al; Wildner, Hendrik; Zeilhofer, H U (2018). Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability. Neuron, 97(4):806-822.e10.

Schliessbach, J; Vuilleumier, P H; Siegenthaler, A; Bütikofer, L; Limacher, A; Juni, P; Zeilhofer, H U; Arendt-Nielsen, L; Curatolo, M (2017). Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain. European Journal of Pain, 21(8):1336-1345.

Zeilhofer, H U; Willis, W D (2013). GABA and Glycine in Spinal Nociceptive Processing. In: Gebhart, Gerald F; Schmidt, Robert F. Encyclopedia of Pain. Berlin: Springer Berlin Heidelberg, 1337-1344.

Zeilhofer, H U; Benke, D; Yévenes, G E (2012). Chronic pain states: Pharmacological strategies to restore diminished inhibitory spinal pain control. Annual Review of Pharmacology and Toxicology, 52(1):111-133.

Zeilhofer, H U; Wildner, H; Yévenes, G E (2012). Fast synaptic inhibition in spinal sensory processing and pain control. Physiological Reviews, 92(1):193-235.

Röhn, T A; Ralvenius, W T; Paul, J; Borter, P; Hernandez, M; Witschi, R; Grest, P; Zeilhofer, H U; Bachmann, M F; Jennings, G T (2011). A Virus-Like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain. Journal of Immunology, 186(3):1769-1780.

Yévenes, G E; Zeilhofer, H U (2011). Allosteric modulation of glycine receptors. British Journal of Pharmacology, 164(2):224-236.

Johansson, T; Narumiya, S; Zeilhofer, H U (2011). Contribution of peripheral versus central EP1 prostaglandin receptors to inflammatory pain. Neuroscience Letters, 495(2):98-101.

Di Lio, A; Benke, D; Besson, M; Desmeules, J; Daali, Y; Wang, Z J; Edwankar, R; Cook, J M; Zeilhofer, H U (2011). HZ166, a novel GABA(A) receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain. Neuropharmacology, 60(4):626-632.

Yévenes, G E; Zeilhofer, H U (2011). Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids. PLoS ONE, 6(8):e23886.

Witschi, R; Punnakkal, P; Paul, J; Walczak, J S; Cervero, F; Fritschy, J M; Kuner, R; Keist, R; Rudolph, U; Zeilhofer, H U (2011). Presynaptic {alpha}2-GABAA receptors in primary afferent depolarization and spinal pain control. Journal of Neuroscience, 31(22):8134-8142.

Tyagarajan, S K; Ghosh, H; Yévenes, G E; Nikonenko, I; Ebeling, C; Schwerdel, C; Sidler, C; Zeilhofer, H U; Gerrits, B; Müller, D; Fritschy, J M (2011). Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(1):379-384.

Zeilhofer, H U (2011). Spinal neuroplasticity in chronic pain. e-Neuroforum, 2(2):35-41.

Witschi, R; Johansson, T; Morscher, G; Scheurer, L; Deschamps, J; Zeilhofer, H U (2010). Hoxb8-CreMice: A tool for brain-sparing conditional gene deletion. Genesis, 48(10):596-602.

Johansson, T; Broll, I; Frenz, T; Hemmers, S; Becher, B; Zeilhofer, H U; Buch, T (2010). Building a zoo of mice for genetic analyses: A comprehensive protocol for the rapid generation of BAC transgenic mice. Genesis: The Journal of Genetics and Development, 48(4):264-280.

Zeilhofer, H U (2010). Spinal cannabinoids – a double-edged sword? (Commentary on Zhang et al.). European Journal of Neuroscience, 31(2):223-224.

Zeilhofer, H U (2009). Etifoxine (Stresam((R))) for chemotherapy-induced pain? Pain, 147(1-3):9-10.

Bagnall, M W; Zingg, B; Sakatos, A; Moghadam, S H; Zeilhofer, H U; Lac, S (2009). Glycinergic projection neurons of the cerebellum. Journal of Neuroscience, 29(32):10104-10110.

Pernía-Andrade, A J; Kato, A; Witschi, R; Nyilas, R; Katona, I; Freund, T F; Watanabe, M; Filitz, J; Koppert, W; Schüttler, J; Ji, G; Neugebauer, V; Marsicano, G; Lutz, B; Vanegas, H; Zeilhofer, H U (2009). Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science, 325(5941):760-764.

Restrepo, C E; Lundfald, L; Szabó, G; Erdélyi, F; Zeilhofer, H U; Glover, J C; Kiehn, O (2009). Transmitter-phenotypes of commissural interneurons in the lumbar spinal cord of newborn mice. Journal of Comparative Neurology, 517(2):177-192.

Zeilhofer, H U; Möhler, H; Di Lio, A (2009). GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends in Pharmacological Sciences, 30(8):397-402.

Zeilhofer, H U; Witschi, R; Johansson, T (2009). Fast inhibitory transmission of pain in the spinal cord. In: Malcangio, M. Synaptic Plasticity in Pain. London: Springer, 49-66.

Zeilhofer, H U; Witschi, R; Hösl, K (2009). Subtype-selective GABA(A) receptor mimetics-novel antihyperalgesic agents? Journal of Molecular Medicine, 87(5):465-469.

Knabl, J; Zeilhofer, U B; Crestani, F; Rudolph, U; Zeilhofer, H U (2009). Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice. Pain, 141(3):233-238.

Andratsch, M; Mair, N; Constantin, C E; Scherbakov, N; Benetti, C; Quarta, S; Vogl, C; Sailer, C A; Uceyler, N; Brockhaus, J; Martini, R; Sommer, C; Zeilhofer, H U; Müller, W; Kuner, R; Davis, J B; Rose-John, S; Kress, M (2009). A key role for gp130 expressed on peripheral sensory nerves in pathological pain. Journal of Neuroscience, 29(43):13473-13483.

Zeilhofer, H U; Zeilhofer, U B (2008). Spinal dis-inhibition in inflammatory pain. Neuroscience letters, 437(3):170-174.

Zeilhofer, H U (2008). Loss of glycinergic and GABAergic inhibition in chronic pain-contributions of inflammation and microglia. International Immunopharmacology, 8(2):182-187.

Knabl, J; Witschi, R; Hösl, K; Reinold, H; Zeilhofer, U B; Ahmadi, S; Brockhaus, J; Sergejeva, M; Hess, A; Brune, K; Fritschy, J M; Rudolph, U; Möhler, H; Zeilhofer, H U (2008). Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature, 451(7176):330-334.

Lundfald, L; Restrepo, C E; Butt, S J B; Peng, C Y; Droho, S; Endo, T; Zeilhofer, H U; Sharma, K; Kiehn, O (2007). Phenotype of V2-derived interneurons and their relationship to the axon guidance molecule EphA4 in the developing mouse spinal cord. European Journal of Neuroscience, 26(11):2989-3002.

Nazzaro, C; Rizzi, A; Salvadori, S; Guerrini, R; Regoli, D; Zeilhofer, H U; Calo, G (2007). UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides, 28(3):663-669.

Zeilhofer, H U (2007). Prostanoids in nociception and pain. Biochemical Pharmacology, 73(2):165-174.

Hess, A; Sergejeva, M; Budinsky, L; Zeilhofer, H U; Brune, K (2007). Imaging of hyperalgesia in rats by functional MRI. European Journal of Pain, 11(1):109-119.

Hösl, K; Reinold, H; Harvey, R J; Müller, U; Narumiya, S; Zeilhofer, H U (2006). Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor alpha3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection. Pain, 126(1-3):46-53.

Zeilhofer, H U; Brune, K (2006). Analgesic strategies beyond the inhibition of cyclooxygenases. Trends in Pharmacological Sciences, 27(9):467-474.

Dumitrescu, O N; Protti, D A; Majumdar, S; Zeilhofer, H U; Wässle, H (2006). Ionotropic glutamate receptors of amacrine cells of the mouse retina. Visual Neuroscience, 23(1):79-90.

Zeilhofer, H U; Brune, K (2006). Antipyretic analgesics: basic aspects. In: McMahon, S B; Koltzenburg, M. Wall and Melzack's Textbook of Pain. Edinburgh: Elsevier, 459-469.

Rizzi, A; Nazzaro, C; Marzola, G G; Zucchini, S; Trapella, C; Guerrini, R; Zeilhofer, H U; Regoli, D; Calo', G (2006). Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences. Pain, 124(1-2):100-108.

Zeilhofer, H U (2005). The glycinergic control of spinal pain processing. Cellular and Molecular Life Sciences, 62(18):2027-2035.

Reinold, H; Ahmadi, S; Depner, U B; Layh, B; Heindl, C; Hamza, M; Pahl, A; Brune, K; Narumiya, S; Müller, U; Zeilhofer, H U (2005). Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. Journal of Clinical Investigation, 115(3):673-679.

Zeilhofer, H U; Studler, B; Arabadzisz, D; Schweizer, C; Ahmadi, S; Layh, B; Bösl, M R; Fritschy, J M (2005). Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. Journal of Comparative Neurology, 482(2):123-141.

Zeilhofer, H U (2005). Synaptic modulation in pain pathways. In: Offermanns, S. Reviews of Physiology, Biochemistry and Pharmacology. Special Issue on Sensory Systems. Berlin: Springer, 73-100.

Hartmann, B; Ahmadi, S; Heppenstall, P A; Lewin, G R; Schott, C; Borchardt, T; Seeburg, P H; Zeilhofer, H U; Sprengel, R; Kuner, R (2004). The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain. Neuron, 44(4):637-650.

Haverkamp, S; Müller, U; Zeilhofer, H U; Harvey, R J; Wässle, H (2004). Diversity of glycine receptors in the mouse retina: localization of the alpha2 subunit. Journal of Comparative Neurology, 477(4):399-411.

Muth-Selbach, U; Dybek, E; Kollosche, K; Stegmann, J U; Holthusen, H; Lipfert, P; Zeilhofer, H U (2004). The spinal antinociceptive effect of nocistatin in neuropathic rats is blocked by D-serine. Anesthesiology, 101(3):753-758.

Harvey, R J; Depner, U B; Wässle, H; Ahmadi, S; Heindl, C; Reinold, H; Smart, T G; Harvey, K; Schütz, B; Abo-Salem, O M; Zimmer, A; Poisbeau, P; Welzl, H; Wolfer, D P; Betz, H; Zeilhofer, H U; Müller, U (2004). GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science, 304(5672):884-887.

Bayer, K; Ahmadi, S; Zeilhofer, H U (2004). Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology, 46(5):743-749.

Zeilhofer, H U; Brune, K (2003). A role for cyclooxygenase-1 in neuropathic pain? Anesthesiology, 99(5):1043-1044.

Zeilhofer, H U; Calò, G (2003). Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy? Journal of Pharmacology and Experimental Therapeutics, 306(2):423-429.

von Wegerer, J; Becker, K; Glockenhammer, D; Becker, C M; Zeilhofer, H U; Swandulla, D (2003). Spinal inhibitory synaptic transmission in the glycine receptor mouse mutant spastic. Neuroscience Letters, 345(1):45-48.

Ahmadi, S A; Muth-Selbach, U; Lauterbach, A; Lipfert, P; Neuhuber, W L; Zeilhofer, H U (2003). Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science, 300(5628):2094-2097.

Depner, U B; Reinscheid, R K; Takeshima, H; Brune, K; Zeilhofer, H U (2003). Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. European Journal of Neuroscience, 17(11):2381-2387.

Becker, L; von Wegerer, J; Schenkel, J; Zeilhofer, H U; Swandulla, D; Weiher, H (2002). Disease-specific human glycine receptor alpha1 subunit causes hyperekplexia phenotype and impaired glycine- and GABA(A)-receptor transmission in transgenic mice. Journal of Neuroscience, 22(7):2505-2512.

Ahmadi, S; Lippross, S; Neuhuber, W L; Zeilhofer, H U (2002). PGE(2)selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nature Neuroscience, 5(1):34-40.

Maihöfner, C; Schlötzer-Schrehardt, U; Gühring, H; Zeilhofer, H U; Naumann, G O; Pahl, A; Mardin, C; Tamm, E R; Brune, K (2001). Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Investigative Ophthalmology and Visual Science, 42(11):2616-2624.

Ahmadi, S; Kotalla, C; Gühring, H; Takeshima, H; Pahl, A; Zeilhofer, H U (2001). Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor. Molecular Pharmacology, 59(3):612-618.

Ahmadi, S; Liebel, J T; Zeilhofer, H U (2001). The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin. European Journal of Pharmacology, 412(1):39-44.

Gühring, H; Görig, M; Ates, M; Coste, O; Zeilhofer, H U; Pahl, A; Rehse, K; Brune, K (2000). Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. Journal of Neuroscience, 20(17):6714-6720.

Zeilhofer, H U; Muth-Selbach, U; Guhring, H; Erb, K; Ahmadi, S (2000). Selective suppression of inhibitory synaptic transmission by nocistatin in the rat spinal cord dorsal horn. Journal of Neuroscience, 20(13):4922-4929.

Zeilhofer, H U; Schorr, W (2000). Role of interleukin-8 in neutrophil signaling. Current Opinion in Hematology, 7(3):178-182.

Zeilhofer, H U; Blank, N M; Neuhuber, W L; Swandulla, D (2000). Calcium-dependent inactivation of neuronal calcium channel currents is independent of calcineurin. Neuroscience, 95(1):235-241.

This list was generated on Fri Sep 20 13:40:05 2019 CEST.